General
Preferred name
SNS-595 Hydrochloride
Synonyms
VOSAROXIN ()
Voreloxin Hydrochloride ()
Vosaroxin Hydrochloride ()
AG 7352 Hydrochloride ()
Voreloxin (Hydrochloride) ()
Voreloxin (SNS-595) hydrochloride ()
P&D ID
PD088333
CAS
175519-16-1
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Vosaroxin intercalates into DNA in a site-specific manner and blocks the re-ligation process carried out by topoisomerase II during DNA replication. As a result, inhibition of DNA replication, RNA and protein synthesis occurs, followed by cell cycle arrest at G2 phase and induced p53-independent apoptosis. This agent shows a favorable toxicity profile in several aspects: it does not generate reactive oxygen species, as do anthracyclines, reducing the risk of cardiotoxicity; it is not a P-glycoprotein (P-gp) substrate, and thereby evades the common mechanism for multidrug resistance; and it has limited distribution to normal tissues and a more chemically stable molecular structure. (BOC Sciences Bioactive Compounds)
Compound Sets
4
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
9
Properties
(calculated by RDKit )
Molecular Weight
437.09
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
1.39
TPSA
109.58
Fraction CSP3
0.33
Chiral centers
2.0
Largest ring
6.0
QED
0.62
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Apoptosis
DNA Damage/DNA Repair
Cell Cycle/DNA Damage
Target
Topo II
Topoisomerase
Source data